Studying the Skin Microbiome and the Potential of a Topical Probiotic Cream for Patients With Acne
Launched by UNIVERSITY HOSPITAL, ANTWERP · Mar 12, 2018
Trial Information
Current as of June 04, 2025
Unknown status
Keywords
ClinConnect Summary
Probiotics are live micro-organisms which when administered in adequate amounts can exert a health benefit on the host. This health-promoting effects have been extensively studied in the gastrointestinal niche but it becomes more and more clear that other niches are also interesting for the potential of probiotics. Recent breakthroughs in 'next generation sequencing' (NGS) technologies are making it now possible to map the microbiota after DNA extraction, which is very interesting for bacteria that are not or difficult to cultivate. The research into the microbiota of the skin with such new...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • mild to moderate acne
- Exclusion Criteria:
- • local treatments, including cleansers, soaps, antimycotics and antibiotics within 2 weeks prior to start of study
- • use of oral antibiotics within 4 weeks prior to start of study
- • use of systemic retinoids within 6 months prior to start of study
About University Hospital, Antwerp
University Hospital Antwerp is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital fosters a collaborative environment that integrates cutting-edge scientific inquiry with state-of-the-art medical practices. As a prominent sponsor of clinical trials, University Hospital Antwerp is committed to enhancing medical knowledge and improving treatment outcomes across a wide range of specialties, leveraging its expertise to contribute significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edegem, Antwerp, Belgium
Patients applied
Trial Officials
Julien Lambert, Prof. dr
Principal Investigator
University Hospital, Antwerp
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials